MOTS-c
Mitochondrial Open Reading Frame of the 12S rRNA-c
MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial 12S rRNA gene — making it a mitochondria-derived peptide (mitokine). It regulates metabolic homeostasis, insulin sensitivity, and cellular stress resistance. Animal studies demonstrate exercise-mimicking effects and lifespan extension, establishing MOTS-c as a key focus in longevity and metabolic research.
Mechanism of Action
MOTS-c activates AMPK (AMP-activated protein kinase), the master energy sensor of the cell. AMPK activation inhibits anabolic energy-consuming pathways, stimulates glucose uptake, drives fatty acid oxidation, and promotes mitochondrial biogenesis — collectively mimicking the molecular effects of exercise.
MOTS-c translocates from mitochondria to the nucleus in response to metabolic stress, where it functions as a transcriptional regulator of stress response genes. This mitochondria-to-nucleus signalling pathway is thought to coordinate whole-cell and whole-organism metabolic adaptations.
In aged mice, MOTS-c levels decline markedly. Administration of exogenous MOTS-c restores metabolic flexibility, reduces adiposity, and has been shown to extend lifespan in multiple rodent ageing models — supporting a causal role in age-related metabolic decline.
Research Evidence
MOTS-c research has expanded rapidly since its discovery in 2015. Human plasma MOTS-c levels correlate inversely with age and with metabolic disease risk, supporting its physiological relevance in human ageing.
MOTS-c: A Mitochondrial-Encoded Regulator of the Methionine Cycle
Discovery paper: MOTS-c regulates the methionine cycle and folate-SHMT axis, impairs de novo purine synthesis, and activates AMPK — producing insulin sensitisation and obesity resistance in mice.
MOTS-c Extends Lifespan in Male Mice on a High-Fat Diet
Aged male mice receiving MOTS-c for 2 months showed improved exercise capacity, muscle function, and reduced all-cause mortality — phenocopying exercise training in aged sedentary mice.
Typical Research Protocol
MOTS-c research protocols vary widely. Some use daily low-dose (2–5mg/day) while others use 3x weekly higher-dose approaches. Human optimal dosing is not established.
Safety Profile
Reported Side Effects
- Injection site redness
- Mild fatigue (first week)
- Increased appetite (possible)
Contraindications
- Pregnancy (no data)
- Insulin-dependent diabetes (AMPK effects on glucose — monitor closely)
- Active malignancy (AMPK has pro-survival roles in some cancers)
Common Research Stacks
Frequently Asked Questions
Is MOTS-c an exercise mimetic?
In animal studies, MOTS-c phenocopies many molecular effects of aerobic exercise — AMPK activation, improved insulin sensitivity, enhanced fat oxidation, and mitochondrial biogenesis. Whether it replicates all exercise benefits in humans is not yet established. It is studied as a potential intervention for populations unable to exercise (frailty, disability) as well as an enhancer of exercise adaptations.
How does MOTS-c differ from Humanin?
Both are mitochondria-derived peptides (MDPs) encoded in mitochondrial DNA, but they have distinct mechanisms. MOTS-c is encoded by the 12S rRNA gene and primarily regulates metabolic homeostasis via AMPK activation. Humanin is encoded by the 16S rRNA gene and focuses on neuroprotection, insulin signalling, and cardiovascular protection. They have complementary rather than overlapping biology.
Does MOTS-c have cardiovascular benefits?
Preclinical research suggests MOTS-c has cardioprotective properties — it reduces oxidative stress in cardiomyocytes, improves vascular endothelial function, and may reduce atherosclerotic plaque formation via AMPK-driven anti-inflammatory effects. Human cardiovascular data is not yet available, but the mechanistic basis for cardiac benefits is well-supported in animal models.
What is the relationship between MOTS-c and longevity?
Plasma MOTS-c levels decline with age in humans and are lower in individuals with age-related metabolic diseases. In Japanese supercentenarians (100+ years), specific mitochondrial polymorphisms associated with higher MOTS-c production are enriched compared to the general population, suggesting genetic MOTS-c upregulation contributes to exceptional longevity. This epidemiological link strengthens the mechanistic case for MOTS-c as a longevity-relevant target.
Does MOTS-c improve insulin sensitivity?
Yes — insulin sensitisation is one of MOTS-c's most robust effects. Through AMPK activation and methionine cycle regulation, MOTS-c improves glucose uptake in skeletal muscle and reduces hepatic glucose output. In diet-induced obese mouse models, MOTS-c administration normalised blood glucose, reduced insulin resistance markers, and improved metabolic flexibility comparable to exercise training interventions.
Key Research References
- Lee C et al. (2015). The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis. Cell Metab.
- Reynolds JC et al. (2021). MOTS-c is an exercise-induced mitochondrial encoded regulator. Nat Commun.
Explore more Longevity research compounds
Browse Longevity →